Overview

Iron Supplementation of Lead-exposed Infants

Status:
Completed

Trial end date:
2008-07-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to compare the efficacy of iron (12.5 mg as ferrous sulfate) and placebo given for 6 months in preventing the elevation of blood lead concentration in children 6-9 months of age.

Phase:

Phase 2

Details

Lead Sponsor:

Cornell University

Collaborator:

Thrasher Research Fund